Skip to main content
. 2022 Mar 17;9:817826. doi: 10.3389/fcvm.2022.817826

TABLE 1.

Characteristics of patients treated with rivaroxaban, apixaban or edoxaban (n = 845).

Patients treated with
Rivaroxaban Apixaban Edoxaban All Missing data
Patients (n/%) 374 (44.3) 405 (47.9) 66 (7.8) 845 (100) 0
Age (years; median/IQR) 74 78 75 76 96
(63-83) (63-83) (58-82) (66-82)
Sex (n/%) 8
Male 209 (56.0) 233 (58.4) 36 (55.4) 478 (57.1)
Female 164 (44.0) 166 (41.6) 29 (44.6) 359 (42.9)

N, number. IQR, interquartile range.